Spironolactone for acne in women

Drug Ther Bull. 2023 Sep;61(9):132. doi: 10.1136/dtb.2023.000040. Epub 2023 Jul 19.

Abstract

Overview of: Santer M, Lawrence M, Renz S, et al. Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ. 2023;381:e074349.

Keywords: Drug-Related Side Effects and Adverse Reactions; Health Care Quality, Access, and Evaluation.

Publication types

  • Review

MeSH terms

  • Acne Vulgaris* / drug therapy
  • England
  • Female
  • Humans
  • Mineralocorticoid Receptor Antagonists / adverse effects
  • Spironolactone* / adverse effects

Substances

  • Mineralocorticoid Receptor Antagonists
  • Spironolactone